Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma

Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia

(2018) Despina Piatopoulou et al.   ANNALS OF HEMATOLOGY

Tumor Expression ofmiR-10b, miR-21, miR-143andmiR-145Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population

(2018) RADKA OBERMANNOVA et al.   ANTICANCER RESEARCH

Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer

(2018) Takashi Sakaguchi et al.   BRITISH JOURNAL OF CANCER

Expression profile of circulating microRNAs in the Correa pathway of progression to gastric cancer

(2018) Sergio Lario et al.   United European Gastroenterology Journal

Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas

(2017) Nina Dusílková et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The expression level of miR-203 in patients with gastric cancer and its clinical significance

(2017) Yushuang Zheng et al.   PATHOLOGY RESEARCH AND PRACTICE

A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma

(2017) Hai-wei Liang et al.   OncoTargets and Therapy

Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis

(2016) Tarek Kamal Motawi et al.   CELL BIOCHEMISTRY AND FUNCTION

miR-203 inhibits cell growth and regulates G1/S transition by targeting Bmi-1 in myeloma cells

(2016) Shun-Quan Wu et al.   Molecular Medicine Reports

Circulating microRNA expression profile in B-cell acute lymphoblastic leukemia

(2015) Claudia Maribel Luna-Aguirre et al.   Cancer Biomarkers

Versican and its associated molecules: Potential diagnostic markers for multiple myeloma

(2015) Nidhi Gupta et al.   CLINICA CHIMICA ACTA

miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients

(2015) Katharina Troppan et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity

(2015) Lavinia Raimondi et al.   Oncotarget

MicroRNA-203 inhibits malignant melanoma cell migration by targeting versican

(2014) PINGYUAN BU et al.   Experimental and Therapeutic Medicine

Versican 3′-untranslated region (3′-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity

(2012) Ling Fang et al.   FASEB JOURNAL

MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival

(2011) Jianxiang Chi et al.   Biology Direct

Epigenetic silencing of MIR203 in multiple myeloma

(2011) Kwan-Yeung Wong et al.   BRITISH JOURNAL OF HAEMATOLOGY

Multiple Myeloma

(2011) Antonio Palumbo et al.   NEW ENGLAND JOURNAL OF MEDICINE

MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis

(2010) Wen Gao et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Expression of Versican 3′-Untranslated Region Modulates Endogenous MicroRNA Functions

(2010) Daniel Y. Lee et al.   PLoS One

Multiple myeloma

(2008) R. A. Kyle et al.   BLOOD